Molecular Templates Inc (NASDAQ:MTEM)

8.92
Delayed Data
As of Nov 30
 -0.17 / -1.86%
Today’s Change
7.51
Today|||52-Week Range
19.12
-36.22%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$455.7M

Company Description

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

Contact Information

Molecular Templates, Inc.
9301 Amberglen Boulevard
Austin Texas 78729
P:(512) 869-1555
Investor Relations:

Employees

Shareholders

Other institutional39.28%
Individual stakeholders38.14%
Mutual fund holders23.24%

Top Executives

Eric E. PomaCEO, Director & Chief Scientific Officer
Jason S. KimPresident & Chief Operating Officer
Adam Daniel CutlerChief Financial Officer, Secretary & Treasurer
Roger J. WaltzmanChief Medical Officer